KATHRYN KIZZAR: Open Payments
NPI 1912463589 · APPLE VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 15 payments from 10 companies in 2025. Trend: 2023 $613 · 2024 $160 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 1 | $122 |
| Novo Nordisk Inc | 4 | $118 |
| Gilead Sciences, Inc. | 2 | $36 |
| Cranial Technologies, Inc | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| PFIZER INC. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: The Cologuard Plus Collection Kit, Wegovy, Ozempic, Doc Band, GEMTESA, MOUNJARO, PREVNAR 20, OFEV.
Industry payments across CA — which companies pay providers there.
